Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiayuan Sun

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Respiration; International Review of Thoracic Diseases|October 27, 2025
Endoscopic Ablation for Malignant Lung Lesions: Current Techniques, Unmet Needs, and Future DirectionsSebastian Fernandez-Bussy, Paola Gutierrez-Gallegos, Alejandra Yu Lee-Mateus, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2024
nCas9 Engineering for Improved Target Interaction Presents an Effective Strategy to Enhance Base EditingGuiquan Zhang, Ziguo Song, Shisheng Huang, et al.
Frontiers in Oncology|August 8, 2022
Electrical Impedance Analysis for Lung Cancer: A Prospective, Multicenter, Blind Validation StudyDawei Yang, Chuanjia Gu, Ye Gu, et al.
Theranostics|April 26, 2021
Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinomaXiao Zhang, Keke Yu, Lifang Ma, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2019
Diagnosing a solitary pulmonary nodule using multiple bronchoscopic guided technologies: A prospective randomized studyLiyan Bo, Congcong Li, Lei Pan, et al.
The Lancet. Global Health|July 2, 2017
National incidence of traumatic fractures in China: a retrospective survey of 512 187 individualsWei Chen, Hongzhi Lv, Song Liu, et al.
The European Respiratory Journal|December 23, 2018
Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapyJun Lu, Hua Zhong, Tianqing Chu, et al.
The Oncologist|August 31, 2018
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) <i>EGFR</i> Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II StudyLiwen Xiong, Rong Li, Jiayuan Sun, et al.
Nature Cell Biology|August 8, 2025
Diet-derived galactose reprograms hepatocytes to prevent T cell exhaustion and elicit antitumour immunityXian Du, Wenyan Li, Guiying Li, et al.
Cell Reports. Medicine|August 26, 2025
An age-related decrease in leptin contributes to CD8<sup>+</sup> T cell aging in the tumor microenvironmentFeixiang Wang, Rujuan Bao, Shuiyu Xu, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Respiration; International Review of Thoracic Diseases|October 27, 2025
Endoscopic Ablation for Malignant Lung Lesions: Current Techniques, Unmet Needs, and Future DirectionsSebastian Fernandez-Bussy, Paola Gutierrez-Gallegos, Alejandra Yu Lee-Mateus, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2024
nCas9 Engineering for Improved Target Interaction Presents an Effective Strategy to Enhance Base EditingGuiquan Zhang, Ziguo Song, Shisheng Huang, et al.
Frontiers in Oncology|August 8, 2022
Electrical Impedance Analysis for Lung Cancer: A Prospective, Multicenter, Blind Validation StudyDawei Yang, Chuanjia Gu, Ye Gu, et al.
Theranostics|April 26, 2021
Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinomaXiao Zhang, Keke Yu, Lifang Ma, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2019
Diagnosing a solitary pulmonary nodule using multiple bronchoscopic guided technologies: A prospective randomized studyLiyan Bo, Congcong Li, Lei Pan, et al.
The Lancet. Global Health|July 2, 2017
National incidence of traumatic fractures in China: a retrospective survey of 512 187 individualsWei Chen, Hongzhi Lv, Song Liu, et al.
The European Respiratory Journal|December 23, 2018
Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapyJun Lu, Hua Zhong, Tianqing Chu, et al.
The Oncologist|August 31, 2018
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) <i>EGFR</i> Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II StudyLiwen Xiong, Rong Li, Jiayuan Sun, et al.
Nature Cell Biology|August 8, 2025
Diet-derived galactose reprograms hepatocytes to prevent T cell exhaustion and elicit antitumour immunityXian Du, Wenyan Li, Guiying Li, et al.
Cell Reports. Medicine|August 26, 2025
An age-related decrease in leptin contributes to CD8<sup>+</sup> T cell aging in the tumor microenvironmentFeixiang Wang, Rujuan Bao, Shuiyu Xu, et al.
Pageof 15